Enhancement Without Contrast: Stability-Aware Multicenter Machine Learning for Glioma MRI Imaging
Authors:
Open Access
- 26 January 2026
- journal article
- research article
- Published by MDPI AG in Inventions
- Vol. 11 (1) , 11
Abstract
Gadolinium-based contrast agents (GBCAs) are vital for glioma imaging yet pose safety, cost, and accessibility issues; predicting contrast enhancement from non-contrast MRI via machine learning (ML) provides a safer, economical alternative, as enhancement indicates tumor aggressiveness and informs treatment planning. However, scanner and population variability hinder robust model selection. To overcome this, a stability-aware framework was developed to identify reproducible ML pipelines for predicting glioma contrast enhancement across multicenter cohorts. A total of 1367 glioma cases from four TCIA datasets (UCSF-PDGM, UPENN-GB, BRATS-Africa, BRATS-TCGA-LGG) were analyzed, using non-contrast T1-weighted images as input and deriving enhancement status from paired post-contrast T1-weighted images; 108 IBSI-standardized radiomics features were extracted via PyRadiomics 3.1, then systematically combined with 48 dimensionality reduction algorithms and 25 classifiers into 1200 pipelines, evaluated through rotational validation (training on three datasets, external testing on the fourth, repeated across rotations) incorporating five-fold cross-validation and a composite score penalizing instability via standard deviation. Cross-validation accuracies spanned 0.91–0.96, with external testing yielding 0.87 (UCSF-PDGM), 0.98 (UPENN-GB), and 0.95 (BRATS-Africa), averaging ~0.93; F1, precision, and recall remained stable (0.87–0.96), while ROC-AUC varied (0.50–0.82) due to cohort heterogeneity, with the MI + ETr pipeline ranking highest for balanced accuracy and stability. This framework enables reliable, generalizable prediction of contrast enhancement from non-contrast glioma MRI, minimizing GBCA dependence and offering a scalable template for reproducible ML in neuro-oncology.Keywords
All Related Versions
Funding Information
- Canadian Foundation for Innovation—John R. Evans Leaders Fund (AWD-023869 CFI)
- Natural Sciences and Engineering Research Council of Canada (AWD-024385)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2023-0357)
- Discovery Horizons (DH-2025-00119)
This publication has 34 references indexed in Scilit:
- Artificial Intelligence in Medical Affairs: A New Paradigm with Novel OpportunitiesPharmaceutical Medicine, 2024
- Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic featuresPhysica Medica, 2023
- Bringing MRI to low‐ and middle‐income countries: Directions, challenges and potential solutionsNMR in Biomedicine, 2023
- The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsScientific Data, 2022
- Federated learning for multi-center imaging diagnostics: a simulation study in cardiovascular diseaseScientific Reports, 2022
- Feature selection and machine learning methods for optimal identification and prediction of subtypes in Parkinson's diseaseComputer Methods and Programs in Biomedicine, 2021
- Robust identification of Parkinson's disease subtypes using radiomics and hybrid machine learningComputers in Biology and Medicine, 2021
- MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variabilityScientific Reports, 2020
- Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmationPediatric Radiology, 2020
- The trends in incidence of primary brain tumors in the population of rochester, minnesotaAnnals of Neurology, 1995